Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin 5-Day vs 10-Day Regimen for Acute Bacterial Sinusitis
NCT00236522Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2002
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levofloxacin in acute bacterial sinusitis (ABS), sponsored by Johnson & Johnson. Started Oct 2002; status: completed.
02
Drugs
levofloxacin
03
Conditions
acute bacterial sinusitis (ABS)
Beyond the preview
Go deeper on NCT00236522.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00236522.